Explore by goal
Weight Loss
Compare clinician-guided weight-loss programs, including semaglutide and tirzepatide pathways, with route, pricing, eligibility and follow-up explained clearly.
What to consider
Semaglutide and tirzepatide pathways
Compare clinician-guided weight-loss programs, including semaglutide and tirzepatide pathways, with route, pricing, eligibility and follow-up explained clearly.
0 programs
Weight Loss programs
Consider This
Learn before you choose
FAQ
Questions worth asking
What is the difference between semaglutide and tirzepatide?
Both are incretin-based medications, but they act on different receptor pathways. A clinician considers medical history, goals, tolerability, access and the exact product before recommending one.
Does exploring a WeightCare page mean I qualify?
No. Eligibility depends on a licensed clinician review and may vary by state, health history, current medications and pharmacy availability.
What does a lower-dose pathway mean?
It describes a dosing philosophy, not a guaranteed side-effect profile or result. The prescriber determines whether a lower starting or maintenance approach is clinically appropriate.
Are compounded GLP-1 products FDA approved?
No. Compounded drugs are not FDA approved. Their use must fit applicable law and an individual prescription, and they should not be represented as equivalent to an FDA-approved product.
Authoritative starting points
Private clinician review
Find the path that fits the whole picture.
Program pages are educational. Eligibility, treatment, route and availability are determined only after an independent clinical evaluation.